"传染性"的移植耐受性
1Department of Pathology, University of Cambridge, United Kingdom.
概括
研究人员使用抗体治疗研究了小鼠的移植耐受性. 耐受性T细胞将这种耐受性传播给新细胞,解释了长期接受移植而没有持续的免疫抑制.
科学领域:
- 免疫学 免疫学 免疫学
- 移植生物学 移植生物学
背景情况:
- 保持移植耐受性对于移植的存活至关重要.
- 短期免疫抑制可以诱导长期耐受性.
研究的目的:
- 研究短期抗体治疗诱导的维持移植耐受性的机制.
- 了解如何在没有持续免疫抑制的情况下维持耐受性.
主要方法:
- 成年小鼠接受了针对CD4和CD8.8的短期非性单克隆抗体治疗.
- 对T细胞种群及其在耐受性接受者中的功能进行分析.
主要成果:
- 来自耐受性小鼠的T细胞可以禁用天真的淋巴细胞,防止移植的拒绝.
- 这种致残效应是可转移的,诱导了原始淋巴细胞的耐受性.
- 确定了一种称为"传染性"耐受性的过程.
结论:
- 由CD4+T细胞介导的"传染性"耐受性解释了长期维持移植耐受性的原因.
- 这种机制避免了在初始诱导后持续免疫抑制的需要.
相关概念视频
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...


